Literature DB >> 33666647

Group 2 innate lymphoid cells support hematopoietic recovery under stress conditions.

Takao Sudo1,2,3, Yasutaka Motomura2,4,5, Daisuke Okuzaki6,7, Tetsuo Hasegawa1, Takafumi Yokota3, Junichi Kikuta1,2,8, Tomoka Ao1,8, Hiroki Mizuno1,2, Takahiro Matsui1,9, Daisuke Motooka6,7, Ryosuke Yoshizawa1, Takashi Nagasawa2,10, Yuzuru Kanakura3, Kazuyo Moro2,4,5, Masaru Ishii1,2,8.   

Abstract

The cell-cycle status of hematopoietic stem and progenitor cells (HSPCs) becomes activated following chemotherapy-induced stress, promoting bone marrow (BM) regeneration; however, the underlying molecular mechanism remains elusive. Here we show that BM-resident group 2 innate lymphoid cells (ILC2s) support the recovery of HSPCs from 5-fluorouracil (5-FU)-induced stress by secreting granulocyte-macrophage colony-stimulating factor (GM-CSF). Mechanistically, IL-33 released from chemo-sensitive B cell progenitors activates MyD88-mediated secretion of GM-CSF in ILC2, suggesting the existence of a B cell-ILC2 axis for maintaining hematopoietic homeostasis. GM-CSF knockout mice treated with 5-FU showed severe loss of myeloid lineage cells, causing lethality, which was rescued by transferring BM ILC2s from wild-type mice. Further, the adoptive transfer of ILC2s to 5-FU-treated mice accelerates hematopoietic recovery, while the reduction of ILC2s results in the opposite effect. Thus, ILC2s may function by "sensing" the damaged BM spaces and subsequently support hematopoietic recovery under stress conditions.
© 2021 Sudo et al.

Entities:  

Year:  2021        PMID: 33666647     DOI: 10.1084/jem.20200817

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

Review 1.  Trained immunity in type 2 immune responses.

Authors:  Franziska Hartung; Julia Esser-von Bieren
Journal:  Mucosal Immunol       Date:  2022-09-05       Impact factor: 8.701

Review 2.  The Dynamic Contribution of Neutrophils in the Chronic Respiratory Diseases.

Authors:  Jongho Ham; Jihyun Kim; Young Gyun Ko; Hye Young Kim
Journal:  Allergy Asthma Immunol Res       Date:  2022-07       Impact factor: 5.096

Review 3.  ILC2s - development, divergence, dispersal.

Authors:  Roberto R Ricardo-Gonzalez; Ari B Molofsky; Richard M Locksley
Journal:  Curr Opin Immunol       Date:  2022-02-14       Impact factor: 7.268

4.  ATP citrate lyase controls hematopoietic stem cell fate and supports bone marrow regeneration.

Authors:  Terumasa Umemoto; Alban Johansson; Shah Adil Ishtiyaq Ahmad; Michihiro Hashimoto; Sho Kubota; Kenta Kikuchi; Haruki Odaka; Takumi Era; Daisuke Kurotaki; Goro Sashida; Toshio Suda
Journal:  EMBO J       Date:  2022-03-01       Impact factor: 14.012

5.  Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time?

Authors:  Hillard M Lazarus; Carolyn E Ragsdale; Robert Peter Gale; Gary H Lyman
Journal:  Front Immunol       Date:  2021-08-17       Impact factor: 7.561

6.  Type 2 Diabetes Mellitus and Latent Tuberculosis Infection Moderately Influence Innate Lymphoid Cell Immune Responses in Uganda.

Authors:  Phillip Ssekamatte; Marjorie Nakibuule; Rose Nabatanzi; Moses Egesa; Carol Musubika; Mudarshiru Bbuye; Matthew R Hepworth; Derek G Doherty; Stephen Cose; Irene Andia Biraro
Journal:  Front Immunol       Date:  2021-08-27       Impact factor: 7.561

7.  Alveolar macrophages rely on GM-CSF from alveolar epithelial type 2 cells before and after birth.

Authors:  Julia Gschwend; Samantha P M Sherman; Frederike Ridder; Xiaogang Feng; Hong-Erh Liang; Richard M Locksley; Burkhard Becher; Christoph Schneider
Journal:  J Exp Med       Date:  2021-08-25       Impact factor: 14.307

Review 8.  Innate Lymphoid Cells in the Central Nervous System.

Authors:  Shuaiwei Wang; Serge A van de Pavert
Journal:  Front Immunol       Date:  2022-02-03       Impact factor: 7.561

9.  The bacterial microbiota regulates normal hematopoiesis via metabolite-induced type 1 interferon signaling.

Authors:  Hannah Yan; Forrest C Walker; Arushana Ali; Hyojeong Han; Lin Tan; Lucas Veillon; Philip L Lorenzi; Megan T Baldridge; Katherine Y King
Journal:  Blood Adv       Date:  2022-03-22

Review 10.  Role of ILC2s in Solid Tumors: Facilitate or Inhibit?

Authors:  Lige Wu; Weiqing Zhao; Shuxian Tang; Rui Chen; Mei Ji; Xin Yang
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.